Phillipa Smith

Intensive blood pressure reduction with intravenous thrombolysis therapy for acute ischaemic stroke (ENCHANTED): an international, randomised, open-label, blinded-endpoint, phase 3 trial.

S. M. Park, M. N. Duy, Le Tuan Linh, 2019, Lancet.

Ronacaleret, a calcium-sensing receptor antagonist, has no significant effect on radial fracture healing time: results of a randomized, double-blinded, placebo-controlled Phase II clinical trial.

L. Fitzpatrick, D. Gordon, M. Fries, 2011, Bone.

Can Waterlow score predict 30-day mortality and length of stay in acutely admitted medical patients (aged ≥65 years)? Evidence from a single centre prospective cohort study

T. Holme, S. Sarker, M. Lynch, 2019, BMJ Open.

Impact of Evidence‐Based Stroke Care on Patient Outcomes: A Multilevel Analysis of an International Study

Sarah S Richtering, Y. Liu, M. Woodward, 2019, Journal of the American Heart Association.